Biomapas

Biomapas

Full lifecycle clinical research outsourcing solutions

Overview

Biomapas provides full outsourcing for the global life sciences sector, handling clinical research, regulatory submissions, and pharmacovigilance across biopharmaceuticals, medical devices, cosmetics, and dietary supplements. Its in-house team conducts studies and regulatory activities in high-recruiting countries and supports Europe, CIS, MENA, and LATAM from early development through commercialization. The approach is integrated and hands-on, with solutions tailored to client needs and delivered as part of the client team to address complex challenges efficiently. The company aims to help clients bring products to market on time and within budget by offering end-to-end, reliable services from a single partner.

About Biomapas

Simplify's Rating
Why Biomapas is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Healthcare

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

Kaunas, Lithuania

Founded

2001

Get referred to Biomapas

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • February 2026 leadership reset brought Xavier Duburcq, likely sharpening execution and acquisition pace.
  • Biomapas Bulletin 19th Edition shows active thought leadership on AI, Bayesian methods, oncology.
  • Delta PV’s 2025 purchase expanded pharmacovigilance capacity for faster global cross-selling.

What critics are saying

  • Xavier Duburcq replaced David Passov on 25 February 2026, signaling leadership instability.
  • Delta PV integration can disrupt clients if systems, quality controls, and teams mismatch.
  • Mid-market CRO consolidation compresses pricing; IQVIA, PPD, and local specialists squeeze margins.

What makes Biomapas unique

  • Biomapas spans clinical, regulatory, pharmacovigilance, and medical information across Europe.
  • Delta PV acquisition adds automated safety workflows and broader MENA, APAC, CIS reach.
  • Carbyne’s backing supports roll-up strategy toward a €200m-plus life-sciences platform.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Remote Work Options

Wellness Program

Home Office Stipend

Performance Bonus

Employee Referral Bonus

Company Social Events

Company News

Biomapas
Feb 24th, 2025
Biomapas Welcomes David Passov as Chief Executive Officer

Biomapas Group is pleased to announce the appointment of David Passov, MBA, as its new Chief Executive Officer, effective 21st February 2025.

Recently Posted Jobs

Sign up to get curated job recommendations

Biomapas is Hiring for 2 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →